eBook: Heralding mRNA and NRTIs - Perspectives on Drug Invention and Development
Read about the invention stories of Messenger RNA (mRNA) and nucleoside reverse-transcriptase inhibitors (NRTIs)
Bioprocess International sponsored by Roche CustomBiotech
Follow Nobel laureate Katalin Karikó, Dennis C. Liotta, and IP advocate Joseph P. Allen as they share insights on translating innovative pharmaceutical modalities from research to commercialization.
mRNA and NRTIs represent two of today's most discussed pharmaceutical modalities. The former drug class has become a household name because of its critical role in ameliorating the COVID-19 pandemic. NRTIs gained importance as small molecule drug in HIV/AIDS treatment.
Highlights:
Explore the critical role of mRNA in combating COVID-19
Discover the revolutionary impact of NRTIs in HIV/AIDS treatment
Gain insights from intellectual property advocate Joseph P. Allen on the legal conditions enabling drug innovation
Uncover the difficulties in translating research to drug development and commercialization
Delve into the importance of IP protection and decentralized technology management
